|
Table 1: Recurrent mitral regurgitation ≥ 3+ after transcatheter edge to edge repair. |
|||
|
Study/Author |
Year |
Recurrent MR ≥ 3+ (%) |
Follow-up (years) |
|
EVEREST II24 |
2015 |
19.0 |
5 |
|
Kar27 |
2019 |
25.0 |
5 |
|
GRASP-IT26 |
2019 |
22.4 |
5 |
|
MitraSwiss28 |
2020 |
31.8 |
5 |
|
Oztürk25 |
2021 |
7.2 |
5 |
|
COAPT29 |
2023 |
5.3 |
5 |
|
Upon removing the COAPT trial data, which solely represent functional mitral regurgitation, the following results were obtained at five years of follow-up: median: 22.4%, mean: 21 ± 3%. MR = mitral regurgitation. |
|||